Ads
related to: biotech companies in bothell wa areaus.jobrapido.com has been visited by 1M+ users in the past month
Search results
Results from the WOW.Com Content Network
Lundbeck Seattle Biopharmaceuticals is a pharmaceutical development company based in Bothell, Washington. Formerly known as Alder Biopharmaceuticals, it specializes in therapeutic monoclonal antibodies. In May 2014, Alder went public. [1] In early 2018, the company made a public stock offering, aiming to raise US$250 million. [2]
The company, headquartered in Bothell, Washington (a suburb of Seattle), is the industry leader in antibody-drug conjugates or ADCs, a technology designed to harness the targeting ability of monoclonal antibodies to deliver cell-killing agents directly to cancer cells. Antibody-drug conjugates are intended to spare non-targeted cells and thus ...
[4] [64] Icos was the largest biotechnology company in the state of Washington at the time of the acquisition, and employed around 700 people. [4] [65] In December 2007, CMC Biopharmaceuticals A/S, a Copenhagen-based provider of contract biomanufacturing services, bought the Bothell biologics facility and retained the existing 127 employees. [4]
Ventec Life Systems was founded in Bothell, Washington, a suburb of Seattle, [2] by Doug DeVries. [3] According to the New York Times, Ventec is known for its VOCSN model, which received approval from the Food and Drug Administration in 2017. The VOCSN is the size of a large toaster oven, and combines a number of functions that had previously ...
In 2001, the company added natural product isolation and identification technology through the acquisition of New Chemical Entities of Bothell, WA. [8] In early 2001, AMRI began leasing space in 30 Corporate Circle, which was fitted out as discovery chemistry laboratory space. The company then purchased two buildings at 24 and 26 Corporate Circle.
Defunct companies based in Bothell, Washington (2 P) Pages in category "Companies based in Bothell, Washington" The following 7 pages are in this category, out of 7 total.
The company was launched with an initial investment of $120 million, with a remit to develop a pipeline of cancer immunotherapy drugs. [1] The company raised $300 million through private funding and a further $265 million through their IPO. On January 22, 2018, Juno Therapeutics was acquired by biotechnology company Celgene for $9 billion. [2]
Bothell's modern economy is centered around biotechnology and high-tech companies that have facilities that were developed in the late 20th century along North Creek and in the Canyon Park neighborhood, which was annexed by the city in 1992. The annexation also expanded the city limits into Snohomish County.
Ads
related to: biotech companies in bothell wa areaus.jobrapido.com has been visited by 1M+ users in the past month